United States · Laboratory · WATCH
Laboratory developed tests: May 2024 final rule vacated, text reverted
The FDA's page says its 6 May 2024 final rule on laboratory developed tests was vacated by a federal district court on 31 March 2025 and that on 19 September 2025 it issued a final rule reverting the regulation to its earlier text.
Primary source
Food and Drug Administration: the instrument text. Language of the text: English.
Verification record
4 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Instrument Laboratory developed tests: May 2024 final rule vacated, text reverted (21 CFR 809.3(a)) Checked Source fda.gov Instrument title and number as printed on the primary text read. Checked
- Regulator Food and Drug Administration Checked Source fda.gov Issuing body as printed on the primary text read. Checked
- Effective date rule vacated 31 March 2025; reverting final rule 19 September 2025 Checked Source fda.gov Date or standing status as read on the primary text. Checked
- What it requires The FDA's page says its 6 May 2024 final rule on laboratory developed tests was vacated by a federal district court on 31 March 2025 and that on 19 September 2025 it issued a final rule reverting the regulation to its earlier text. Checked Source fda.gov Written from what the primary text states. Checked
Check history: Laboratory developed tests: May 2024 final rule vacated, text reverted was last read in its primary source on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this instrument. To ask for one, write to [email protected] with the instrument's name; every correction is checked against the primary text before the record changes.
At a glance
- Regulator: Food and Drug Administration
- Number: 21 CFR 809.3(a)
- Governs: Laboratory
- Effective: rule vacated 31 March 2025; reverting final rule 19 September 2025
- Status: WATCH
What is being watched
No current federal rule on laboratory developed tests is stated on the page; watch for new FDA or Congressional action.
Country page